Literature DB >> 26884891

The origin and onset of acute venous thrombus.

Lemin Wang1, Qianglin Duan1, Fan Yang2, Siwan Wen1.   

Abstract

Under the condition of immune cell balancing function collapse, acute venous thrombosis originates from intravenous immune adhesive inflammations triggered by cells which are infected by foreign pathogenic microorganism and malignant cells. With the condition of immune cell balancing function collapse, the human body lost the function of clearing intravenous foreign pathogenic microorganism and malignant cells timely and effectively. Thus, integrins β2 and β3 on the membrane of white blood cells and platelets are activated to combine with the ligand fibrinogen into a reversible mesh-like structure, which is like the intravenous biological filter and acts as physical defense of the human body to prevent the cells which are infected by foreign pathogenic microorganism and malignant cells in the distal veins from flowing back to the whole body. Meanwhile, blood cells mainly red blood cells stagnate and fulfill the filter, which blocks the blood flow in the local veins and thus results in venous thrombotic diseases. People with collapsed immune cell balancing functions are the certain groups of people who will develop venous thromboembolism. Anyone who had venous thromboembolism indicates alloantigen cells in the veins, which are mainly pathogenic microorganism infected cells and malignant cells and trigger the onset of venous thromboembolism. Only under the condition of immune cell balancing function collapse, the risk factors, such as advanced age, infection, trauma, surgery, autoimmune disease, pregnancy as well as long trip syndrome, could cause venous thromboembolism.

Entities:  

Keywords:  Origin; core protein; immune cell balancing function; infected cell; malignant cell; venous thromboembolism

Year:  2015        PMID: 26884891      PMCID: PMC4723736     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  36 in total

1.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

Review 2.  Integrin structure.

Authors:  M J Humphries
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

3.  Acute pulmonary embolism and dysfunction of CD3+ CD8+ T cell immunity.

Authors:  Lemin Wang; Haoming Song; Zhu Gong; Qianglin Duan; Aibin Liang
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

4.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Severe acute respiratory syndrome and venous thromboembolism in multiple organs.

Authors:  Yi Xiang-Hua; Wang Le-Min; Liang Ai-Bin; Gong Zhu; Lai Riquan; Zhu Xu-You; Rui Wei-Wei; Wang Ye-Nan
Journal:  Am J Respir Crit Care Med       Date:  2010-08-01       Impact factor: 21.405

6.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Authors:  Helen K Chew; Theodore Wun; Danielle Harvey; Hong Zhou; Richard H White
Journal:  Arch Intern Med       Date:  2006-02-27

Review 7.  Epidemiology of cancer-related venous thromboembolism.

Authors:  Ted Wun; Richard H White
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

8.  Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics.

Authors:  Hao Wang; Qianglin Duan; Lemin Wang; Zhu Gong; Aibin Liang; Qiang Wang; Haoming Song; Fan Yang; Yanli Song
Journal:  Int J Med Sci       Date:  2012-07-11       Impact factor: 3.738

9.  Acute infections and venous thromboembolism.

Authors:  M Schmidt; E Horvath-Puho; R W Thomsen; L Smeeth; H T Sørensen
Journal:  J Intern Med       Date:  2011-12-08       Impact factor: 8.989

10.  Characteristics of the complement system gene expression deficiency in patients with symptomatic pulmonary embolism.

Authors:  Wei Lv; Lemin Wang; Qianglin Duan; Zhu Gong; Fan Yang; Haoming Song; Yanli Song
Journal:  Thromb Res       Date:  2013-05-30       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.